R&D
🇪🇺 EMA Page 3EMA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Gain critical insights into global pharmaceutical R&D trends, drug discovery pipelines, and clinical trial advancements. Drive your pharma strategy.
Showing 25–36 of 37 articles
EMA celebrates diversity and inclusion in science and healthcare
Arrowhead Pharmaceuticals to Participate in Key June 2026 Industry Events
Intellia Therapeutics to Report Additional Phase 3 HAELO Data for Lonvoguran Ziclumeran (lonvo-z) in Late-Breaking Oral Presentation at EAACI 2026
Italy's Clinical Research Landscape: Strengths, Weaknesses, and Strategic Implications
UCB's Bimzelx vs. AbbVie's Skyrizi: Psoriatic Arthritis Competitive Landscape
Eisai's Leqembi Sales Forecast: Projecting Blockbuster Status in Alzheimer's
Germany's Bioeconomy Dialogue: Implications for Pharma
Biosimulation Market to Reach $11.3 Billion by 2031 as Pharmaceutical Companies Accelerate Digital Drug Development
Pharmaceutical Manufacturing Software Market to Reach $7.87 Billion by 2030, Driven by 15.8% CAGR Growth
Kelun-Biotech's Sac-TMT Cancer Drug Selected for Three ASCO 2026 Oral Presentations
AI in European Pharmaceutical R&D: Investment & Regulatory Insights
Gene Therapies for Neurological Disorders: EMA Approval Trends & Insights